Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study

Abstract

Milnacipran did not display a significant analgesic effect after 1-month treatment, but the tendency of milnacipran to reactivate CPM in a number of patients must be explored with longer treatment duration in future studies and pleads for possible subtypes of fibromyalgia patients.